Skip to main navigation Skip to search Skip to main content

Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma

  • Takeshi Hara
  • , Hisashi Tsurumi
  • , Naoe Goto
  • , Jun Ichi Kitagawa
  • , Nobuhiro Kanemura
  • , Takeshi Yoshikawa
  • , Senji Kasahara
  • , Hideko Goto
  • , Kenji Fukuno
  • , Toshiki Yamada
  • , Michio Sawada
  • , Ichiro Yasuda
  • , Naoki Katsumura
  • , Takeshi Takahashi
  • , Tsuyoshi Takami
  • , Hisataka Moriwaki

Research output: Contribution to journal › Article › peer-review

19   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases